Van Eck Associates Corp Bausch Health Companies Inc. Transaction History
Van Eck Associates Corp
- $78.1 Billion
- Q4 2024
A detailed history of Van Eck Associates Corp transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 223,420 shares of BHC stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
223,420
Previous 343,268
34.91%
Holding current value
$1.56 Million
Previous $2.77 Million
34.98%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding BHC
# of Institutions
271Shares Held
252MCall Options Held
5.12MPut Options Held
9.43M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$243 Million3.8% of portfolio
-
Goldentree Asset Management LP New York, NY27.5MShares$193 Million16.77% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$185 Million12.9% of portfolio
-
National Bank Of Canada15.4MShares$108 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$91 Million0.23% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.53B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...